Back to Market Feed

Product Information

METRONIDAZOLE TOPICAL 1% GEL is a generic product labeled by Aurobindo Pharma Limited, priced at $0.6209 per GM under NDC 59651081360. Its NADAC has been published 44 times since Oct 22, 2025.

FDA first approved this application on Oct 15, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METRONIDAZOLE TOPICAL 1% GEL

METRONIDAZOLE
$0.6209per GM

Strength

10 mg/g

NDC

59651081360

Classification

Generic

Dosage Form

GEL

Route

TOPICAL

Effective Date

8/19/2026

Active Ingredients

METRONIDAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA218941

FDA Approved

10/15/2024

TE Code

AB

On Market Since

10/15/2024

Pharmacological Classes

Nitroimidazole Antimicrobial
Nitroimidazoles

Price Statistics

The NADAC for METRONIDAZOLE TOPICAL 1% GEL has been published 44 times since Oct 22, 2025, and over the history we have for it it has declined 18.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6209 per GM
All-time high$0.7658 (Nov 12, 2025)
All-time low$0.6209 (Aug 19, 2026)
52-week high$0.7658
52-week low$0.6209
Median price$0.6748
Average price$0.6877
Largest weekly change-5.4% (Dec 17, 2025)
Weeks tracked44
Tracking sinceOct 22, 2025

Price History

1W

-2.4%

1M

-2.4%

3M

-9.2%

6M

-7.7%

1Y

N/A

3Y

N/A

5Y

N/A

All

-18.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the METRONIDAZOLE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

METRONIDAZOLE 250 MG TABLET
Generic
65862069401•Aurobindo Pharma Limited
$0.0970
per EA
METRONIDAZOLE 250 MG TABLET
Generic
65862069405•Aurobindo Pharma Limited
$0.0970
per EA
METRONIDAZOLE 250 MG TABLET
Generic
65862069425•Aurobindo Pharma Limited
$0.0970
per EA
METRONIDAZOLE 500 MG TABLET
Generic
16571066401•Rising Pharma Holdings Inc.
$0.1012
per EA
METRONIDAZOLE 500 MG TABLET
Generic
16571066450•Rising Pharma Holdings Inc.
$0.1012
per EA
METRONIDAZOLE 500 MG TABLET
Generic
29300022701•Unichem Pharmaceuticals (USA) Inc.
$0.1012
per EA
METRONIDAZOLE 500 MG TABLET
Generic
29300022705•Unichem Pharmaceuticals (USA) Inc.
$0.1012
per EA
METRONIDAZOLE 500 MG TABLET
Generic
29300022746•Unichem Pharmaceuticals (USA) Inc.
$0.1012
per EA
METRONIDAZOLE 500 MG TABLET
Generic
50111033401•Teva Pharmaceuticals USA Inc.
$0.1012
per EA
METRONIDAZOLE 500 MG TABLET
Generic
50111033402•Teva Pharmaceuticals USA Inc.
$0.1012
per EA

Frequently asked questions

What is the NADAC price of METRONIDAZOLE TOPICAL 1% GEL?

The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE TOPICAL 1% GEL, manufactured by Aurobindo Pharma Limited, is $0.6209 per GM (NDC 59651081360), effective Aug 19, 2026.

How has the price of METRONIDAZOLE TOPICAL 1% GEL changed over time?

Over the history we have for it, the NADAC for METRONIDAZOLE TOPICAL 1% GEL has declined 18.9%. It has been tracked across 44 weekly CMS publications since Oct 22, 2025.

What are the highest and lowest recorded NADAC prices for METRONIDAZOLE TOPICAL 1% GEL?

Since Oct 22, 2025, the NADAC for METRONIDAZOLE TOPICAL 1% GEL has ranged from a low of $0.6209 (Aug 19, 2026) to a high of $0.7658 (Nov 12, 2025), with a median of $0.6748 per GM.

Are there cheaper alternatives to METRONIDAZOLE TOPICAL 1% GEL?

No other NADAC-published product currently shares the active ingredient and strength of METRONIDAZOLE TOPICAL 1% GEL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures METRONIDAZOLE TOPICAL 1% GEL?

METRONIDAZOLE TOPICAL 1% GEL (NDC 59651081360) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.